Christoph Luderschmidt

Title: Christoph Luderschmidt: Innovator in Hormonal Treatments

Introduction

Christoph Luderschmidt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of dermatology through his innovative pharmaceutical compositions. With a total of two patents to his name, Luderschmidt's work focuses on hormonal agents for skin treatment.

Latest Patents

Luderschmidt's latest patents include a hormonal agent for skin treatment specifically designed for conditions such as seborrhea and androgenically conditioned alopecia. The pharmaceutical composition contains the gestogen, dienogest, or a combination of dienogest and an estrogen as the active ingredient. The methods for treating these skin conditions involve the topical application of the composition, which results in outstanding sebosuppression, a drastic reduction of androstandiol glucuronide, and moderate competitive blockage of androgen receptor sites. The galenic formulations described in his patents limit and prevent the permeation of the active ingredient through the skin, thereby substantially reducing systemic effects and side reactions.

Career Highlights

Throughout his career, Christoph Luderschmidt has worked with reputable companies such as Jenapharm GmbH & Co. KG and Jenapharm GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to skin treatment.

Collaborations

Luderschmidt has collaborated with notable professionals in his field, including Siegfried Golbs and Michael Oettel. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christoph Luderschmidt is a distinguished inventor whose work in hormonal treatments for skin conditions has made a significant impact in dermatology. His innovative patents reflect his dedication to improving patient care and advancing medical science.